These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 31879047)
21. SPH3643: A novel cyclin-dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood-brain barrier permeability. Liao X; Hong Y; Mao Y; Chen N; Wang Q; Wang Z; Zhang L; Wang L; Shi C; Shi W; Ge H; Li A; Li X; Xia G; Liu Y Cancer Sci; 2020 May; 111(5):1761-1773. PubMed ID: 32103527 [TBL] [Abstract][Full Text] [Related]
22. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1. Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158 [TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of isocryptotanshinone on gastric cancer. Chen ZM; Huang L; Li MM; Meng L; Ying SC; Xu AM Sci Rep; 2018 Jun; 8(1):9307. PubMed ID: 29915371 [TBL] [Abstract][Full Text] [Related]
24. SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling. Yang Q; Wang B; Gao W; Huang S; Liu Z; Li W; Jia J Mol Cancer Res; 2013 Dec; 11(12):1497-507. PubMed ID: 24107295 [TBL] [Abstract][Full Text] [Related]
25. Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway. Liu Y; Gao S; Zhu J; Zheng Y; Zhang H; Sun H Cancer Med; 2018 Nov; 7(11):5704-5715. PubMed ID: 30338663 [TBL] [Abstract][Full Text] [Related]
26. Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling. Tong Y; Liu Y; Zheng H; Zheng L; Liu W; Wu J; Ou R; Zhang G; Li F; Hu M; Liu Z; Lu L Oncotarget; 2016 May; 7(21):31413-28. PubMed ID: 27119499 [TBL] [Abstract][Full Text] [Related]
27. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells. Lin Z; Zhang X; Zhao F; Ru S Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532 [TBL] [Abstract][Full Text] [Related]
28. Kaempferol suppresses proliferation and induces apoptosis and DNA damage in human gallbladder cancer cells through the CDK4/CDK6/cyclin D1 pathway. Liu ZQ; Yao GL; Zhai JM; Hu DW; Fan YG Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1311-1321. PubMed ID: 33629301 [TBL] [Abstract][Full Text] [Related]
29. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. Kennedy AL; Vallurupalli M; Chen L; Crompton B; Cowley G; Vazquez F; Weir BA; Tsherniak A; Parasuraman S; Kim S; Alexe G; Stegmaier K Oncotarget; 2015 Oct; 6(30):30178-93. PubMed ID: 26337082 [TBL] [Abstract][Full Text] [Related]
30. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells. Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361 [TBL] [Abstract][Full Text] [Related]
31. [Artemisinin inhibits proliferation of gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis]. Jia JG; Zhang LG; Guo CX; Wang YG; Chen BL; Wang YM; Qian J Zhonghua Wai Ke Za Zhi; 2016 Mar; 54(3):222-7. PubMed ID: 26932893 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells. Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359 [TBL] [Abstract][Full Text] [Related]
33. The role of TRPV1 ion channels in the suppression of gastric cancer development. Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449 [TBL] [Abstract][Full Text] [Related]
34. Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo. Fujita N; Fujita K; Iwama H; Kobara H; Fujihara S; Chiyo T; Namima D; Yamana H; Kono T; Takuma K; Hirata M; Kobayashi K; Kato K; Kamada H; Morishita A; Tsutsui K; Himoto T; Okano K; Suzuki Y; Masaki T Oncol Rep; 2020 Jul; 44(1):339-348. PubMed ID: 32627043 [TBL] [Abstract][Full Text] [Related]
35. The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation. Yadav V; Burke TF; Huber L; Van Horn RD; Zhang Y; Buchanan SG; Chan EM; Starling JJ; Beckmann RP; Peng SB Mol Cancer Ther; 2014 Oct; 13(10):2253-63. PubMed ID: 25122067 [TBL] [Abstract][Full Text] [Related]
36. Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells. Luo Q; Zhang S; Zhang D; Feng R; Li N; Chen W; Chen X; Yang S Curr Pharm Biotechnol; 2021; 22(4):523-533. PubMed ID: 32576126 [TBL] [Abstract][Full Text] [Related]
37. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression. Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987 [TBL] [Abstract][Full Text] [Related]
38. CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G Chen H; Xu X; Wang G; Zhang B; Wang G; Xin G; Liu J; Jiang Q; Zhang H; Zhang C J Biol Chem; 2017 Jun; 292(24):10131-10141. PubMed ID: 28446612 [TBL] [Abstract][Full Text] [Related]
39. NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion. Xie R; Wang H; Jin H; Wen G; Tuo B; Xu J Oncol Rep; 2017 Mar; 37(3):1451-1460. PubMed ID: 28098891 [TBL] [Abstract][Full Text] [Related]
40. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest. Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]